Inside the First Cannabis Company to List on Nasdaq

Cronos Group started trading on the Nasdaq Tuesday. The vertically integrated company became the first marijuana company to join a major exchange in the United States. The company's CEO Mike Gorenstein explains how Cronos is capitalizing on the emerging market in Canada. "Entering the U.S. market is really big for us," said Gorenstein. "It continues to show the acceptance the Cannabis industry is getting, and the recognition of how important Cannabis can be." Cronos Group fully owns two subsidiary companies Peace Naturals and Original BC (OGBC), with partial stake in Whistler Medical Marijuana Company.

More In Business

How Siri Is About to Get a Whole Lot Smarter

Apple unveils a smarter Siri and major AI updates. Mark Spoonauer, Global Editor-in-Chief at Tom’s Guide, breaks down WWDC 2026.

How to Build a Career That Survives the AI Revolution

As AI reshapes the workforce, author Benjamin Todd explains how graduates can build resilient, fulfilling careers and thrive in a changing job market.

The GLP-1 Effect: How Weight-Loss Drugs Are Changing the Business of Healthcare

America's GLP-1 boom is reshaping healthcare. SHARx co-founder Paul Pruitt explains who pays, why costs are surging, and what comes next.

Experian's AI Strategy Is Reshaping Financial Services

From Money 20/20, Experian UK & Ireland CEO Malin Holmberg discusses the trends, opportunities and innovations shaping fintech's future.

Big Business This Week: Decoding investor FOMO about the AI & SpaceX IPOs

A historic wave of IPOs is about to hit Wall Street. For the average investor watching from the sidelines, the frenzy can engender fears of missing out.

Why AI Companies May Soon Be Sharing Their Most Powerful Models With the Government

Politico's Cheyenne Haslett breaks down Trump's new AI executive order, the AI race with China, industry reaction, and what's next for regulation.

Inside the Aerospace IPO Positioning for the Next Decade of Defense Growth

Applied Aerospace & Defense CEO Trip Ferguson discusses the company's IPO, defense spending, space innovation, and the future of U.S. aerospace manufacturing.

How Crunch Fitness Is Redefining Your Exercise Routine

Jim Rowley, CEO of Crunch Fitness, discusses affordable fitness, industry growth, and why value-focused gyms continue to attract members.

Who Decides? Who Profits? Who Pays? Inside Trump's D.C. Projects

David Fahrenthold, investigative reporter for The New York Times, examines rising costs, contracts, and transparency concerns in Trump's D.C. projects.

Is The Fed About to Make Its Biggest Move Yet?

Megan Leonhardt, Senior Economics Writer at Barron's, breaks down sticky inflation, Fed policy, interest rates and what they mean for consumers.

Load More